{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:04:21Z","timestamp":1790791461922,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41433-026-04358-8","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:15:55Z","timestamp":1775542555000},"page":"1103-1105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A call to develop rigorous standards for excellence in idiopathic intracranial hypertension: RISE-IIH"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8159-0656","authenticated-orcid":false,"given":"Daisy","family":"MacKeith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8240-4225","authenticated-orcid":false,"given":"Jessica","family":"Katanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6392-4927","authenticated-orcid":false,"given":"Arani","family":"Nitkunan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8815-8118","authenticated-orcid":false,"given":"Alis","family":"Sejourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"MacDiarmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3008-4191","authenticated-orcid":false,"given":"Alysha","family":"Budd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Voas-Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3390-9508","authenticated-orcid":false,"given":"Gabriele","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6314-4437","authenticated-orcid":false,"given":"Susan P.","family":"Mollan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2949-1160","authenticated-orcid":false,"given":"Joanne","family":"Adeoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"4358_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-025-01420-y","volume":"25","author":"M Lowe","year":"2025","unstructured":"Lowe M, Berman G, Sumithran P, Mollan SP. Current understanding of the pathophysiology of idiopathic intracranial hypertension. Curr Neurol Neurosci Rep. 2025;25:31. https:\/\/doi.org\/10.1007\/s11910-025-01420-y.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4358_CR2","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41582-023-00893-0","volume":"19","author":"A Yiangou","year":"2023","unstructured":"Yiangou A, Mollan SP, Sinclair AJ. Idiopathic intracranial hypertension: a step change in understanding the disease mechanisms. Nat Rev Neurol. 2023;19:769\u201385. https:\/\/doi.org\/10.1038\/s41582-023-00893-0.","journal-title":"Nat Rev Neurol"},{"key":"4358_CR3","doi-asserted-by":"publisher","first-page":"e000527","DOI":"10.1136\/bmjno-2023-000527","volume":"5","author":"S Abbott","year":"2023","unstructured":"Abbott S, Denton A, Wong SH, Mollan SP, Bul KC. Weight management communications in idiopathic intracranial hypertension: challenges and recommendations from the patients\u2019 perspective. BMJ Neurol Open. 2023;5:e000527 https:\/\/doi.org\/10.1136\/bmjno-2023-000527.","journal-title":"BMJ Neurol Open"},{"key":"4358_CR4","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/jnnp-2017-317440","volume":"89","author":"SP Mollan","year":"2018","unstructured":"Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89:1088\u2013100. https:\/\/doi.org\/10.1136\/jnnp-2017-317440.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4358_CR5","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1038\/s41433-020-01358-0","volume":"35","author":"SP Mollan","year":"2021","unstructured":"Mollan SP, Blanch RJ. Response to \u201cMagnetic resonance or computed tomography venography in the evaluation of young overweight women with papilledema. Eye. 2021;35:3453\u20134. https:\/\/doi.org\/10.1038\/s41433-020-01358-0.","journal-title":"Eye"},{"key":"4358_CR6","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1038\/s41433-024-03141-x","volume":"38","author":"SP Mollan","year":"2024","unstructured":"Mollan SP, Menon V, Cunningham A, Plant GT, Bennetto L, Wong SH, et al. Neuro-ophthalmology in the United Kingdom: providing a sustainable, safe and high-quality service for the future. Eye. 2024;38:2235\u20137. https:\/\/doi.org\/10.1038\/s41433-024-03141-x.","journal-title":"Eye"},{"key":"4358_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/WNO.0000000000001902","volume":"44","author":"H Kobeissi","year":"2024","unstructured":"Kobeissi H, Bilgin C, Ghozy S, Adusumilli G, Thurnham J, Hardy N, et al. Common design and data elements reported on idiopathic intracranial hypertension trials: a systematic review. J Neuroophthalmol. 2024;44:66\u201373. https:\/\/doi.org\/10.1097\/WNO.0000000000001902.","journal-title":"J Neuroophthalmol"},{"key":"4358_CR8","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1212\/cont.0000000000001586","volume":"31","author":"JJ Chen","year":"2025","unstructured":"Chen JJ, Mollan SP. Treatment and monitoring of idiopathic intracranial hypertension. Contin (Minneap Minn). 2025;31:728\u201356. https:\/\/doi.org\/10.1212\/cont.0000000000001586.","journal-title":"Contin (Minneap Minn)"},{"key":"4358_CR9","doi-asserted-by":"publisher","first-page":"e2138","DOI":"10.1212\/WNL.0000000000207866","volume":"101","author":"S Abbott","year":"2023","unstructured":"Abbott S, Chan F, Tahrani AA, Wong SH, Campbell FEJ, Parmar C, et al. Weight management interventions for adults with idiopathic intracranial hypertension: a systematic review and practice recommendations. Neurology. 2023;101:e2138\u2013e2150. https:\/\/doi.org\/10.1212\/WNL.0000000000207866.","journal-title":"Neurology"},{"key":"4358_CR10","doi-asserted-by":"publisher","first-page":"e1090","DOI":"10.1212\/WNL.0000000000200839","volume":"99","author":"SP Mollan","year":"2022","unstructured":"Mollan SP, Mitchell JL, Yiangou A, Ottridge RS, Alimajstorovic Z, Cartwright DM, et al. Association of amount of weight lost after bariatric surgery with intracranial pressure in women with idiopathic intracranial hypertension. Neurology. 2022;99:e1090\u2013e1099. https:\/\/doi.org\/10.1212\/WNL.0000000000200839.","journal-title":"Neurology"},{"key":"4358_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/WNO.0000000000000861","volume":"40","author":"DC Parish","year":"2020","unstructured":"Parish DC, Bidot S, Bruce BB, Micieli JA, Blanch RJ, Newman AB, et al. Self-reported weight and height among idiopathic intracranial hypertension patients. J Neuroophthalmol. 2020;40:157\u201362. https:\/\/doi.org\/10.1097\/WNO.0000000000000861.","journal-title":"J Neuroophthalmol"},{"key":"4358_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/14737175.2024.2359420","volume":"24","author":"O Potter","year":"2024","unstructured":"Potter O, Menon V, Mollan SP. Risk factors and disease associations in people living with idiopathic intracranial hypertension. Expert Rev Neurother. 2024;24:681\u20139. https:\/\/doi.org\/10.1080\/14737175.2024.2359420.","journal-title":"Expert Rev Neurother"},{"key":"4358_CR13","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1001\/jamaneurol.2019.1812","volume":"76","author":"NJ Adderley","year":"2019","unstructured":"Adderley NJ, Subramanian A, Nirantharakumar K, Yiangou A, Gokhale KM, Mollan SP, et al. Association between idiopathic intracranial hypertension and risk of cardiovascular diseases in women in the United Kingdom. JAMA Neurol. 2019;76:1088\u201398. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1812.","journal-title":"JAMA Neurol"},{"key":"4358_CR14","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1038\/s41433-024-03140-y","volume":"38","author":"L Bonelli","year":"2024","unstructured":"Bonelli L, Menon V, Arnold AC, Mollan SP. Managing idiopathic intracranial hypertension in the eye clinic. Eye. 2024;38:2472\u201381. https:\/\/doi.org\/10.1038\/s41433-024-03140-y.","journal-title":"Eye"},{"key":"4358_CR15","unstructured":"National Institute for Health and Care Excellence. Overweight and obesity management NICE guideline [NG246]. 2025. https:\/\/www.nice.org.uk\/guidance\/NG246\/chapter\/medicines-and-surgery. [Accessed 2025 Dec 28]."},{"key":"4358_CR16","doi-asserted-by":"publisher","first-page":"e1968","DOI":"10.1212\/WNL.0000000000201064","volume":"99","author":"NJ Adderley","year":"2022","unstructured":"Adderley NJ, Subramanian A, Perrins M, Nirantharakumar K, Mollan SP, Sinclair AJ. Headache, opiate use, and prescribing trends in women with idiopathic intracranial hypertension: a population-based matched cohort study. Neurology. 2022;99:e1968\u2013e1978. https:\/\/doi.org\/10.1212\/WNL.0000000000201064.","journal-title":"Neurology"},{"key":"4358_CR17","doi-asserted-by":"publisher","unstructured":"Mollan SP, Fraser CL, Digre KB, Diener HC, Lipton RB, Juhler M et al. Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension. Cephalalgia. 2023;43. https:\/\/doi.org\/10.1177\/03331024231197118","DOI":"10.1177\/03331024231197118"},{"key":"4358_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1212\/WNL.0000000000002318","volume":"86","author":"A Fisayo","year":"2016","unstructured":"Fisayo A, Bruce BB, Newman NJ, Biousse V. Overdiagnosis of idiopathic intracranial hypertension. Neurology. 2016;86:341\u201350. https:\/\/doi.org\/10.1212\/WNL.0000000000002318.","journal-title":"Neurology"},{"key":"4358_CR19","doi-asserted-by":"publisher","first-page":"e090521","DOI":"10.1136\/bmjopen-2024-090521","volume":"15","author":"A Huntley","year":"2025","unstructured":"Huntley A, Skrobot O, Ridd MJ, Sherratt MA, Lucraft M, Stokes C, et al. DIPP group. Improving the diagnostic accuracy of referrals for papilloedema (DIPP) study: protocol for a mixed-methods study. BMJ Open. 2025;15:e090521 https:\/\/doi.org\/10.1136\/bmjopen-2024-090521.","journal-title":"BMJ Open"},{"key":"4358_CR20","unstructured":"Department of Health and Social Care. Fit for the future: 10 year health plan for England. 2025 https:\/\/www.gov.uk\/government\/publications\/10-year-health-plan-for-england-fit-for-the-future. [Accessed 28 Dec 2025]"},{"key":"4358_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.22599\/bioj.427","volume":"20","author":"D MacKeith","year":"2024","unstructured":"MacKeith D. Idiopathic Intracranial Hypertension\u2013How Can Orthoptists Help Improve Care? Letter to the editor. Br Ir Orthopt j. 2024;20:258.","journal-title":"Br Ir Orthopt j"},{"key":"4358_CR22","unstructured":"National Neurosciences Advisory Group (NNAG). Optimal clinical care pathway for adults: Multiple Sclerosis. 2024. https:\/\/static1.squarespace.com\/static\/5f1021faf6248b39f4c64f5d\/t\/67580bb1ab6bd82628fb3b5f\/1733823470239\/FINAL+MS+Pathway. https:\/\/www.neural.org.uk\/wp-content\/uploads\/2020\/07\/Optimum-pathway-for-patients-with-MS_updated.1.pdf [Accessed 28 Dec 2025]"},{"key":"4358_CR23","unstructured":"Intercollegiate Stroke Working Party. National Clinical Guideline for Stroke for the UK and Ireland. 2023. www.strokeguideline.org. [Accessed 28 Dec 2025]"},{"key":"4358_CR24","unstructured":"Sentinel Stroke National Audit Programme. National Optimal Stroke Imaging Pathway (NOSIP). 2023. https:\/\/www.strokeaudit.org\/SupportFiles\/Documents\/Annual-report\/2023\/NOSIP-master-version.aspx [Accessed 28 Dec 2025]"},{"key":"4358_CR25","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/rheumatology\/kead025","volume":"62","author":"FL Coath","year":"2023","unstructured":"Coath FL, Bukhari M, Ducker G, Griffiths B, Hamdulay S, Hingorani M, et al. Quality standards for the care of people with giant cell arteritis in secondary care. Rheumatology. 2023;62:3075\u201383.","journal-title":"Rheumatology"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04358-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:59:26Z","timestamp":1779368366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04358-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4358"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04358-8","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Susan Mollan reports consultancy fees (Invex Therapeutics); advisory board fees (Ocular Therapeutix, Domp\u00e9); speaker fees (Teva, AbbVie); Travel (AbbVie, Essilorluxottica, European Alliance of Associations for Rheumatology); Receipt of equipment (Heidelberg Engineering). Susan Mollan is also a member of the\n                      Eye\n                      editorial board. Authors declare no other financial relationships with any organisations that might have an interest in the submitted work, and no other relationships or activities that could appear to have influenced the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}